129 related articles for article (PubMed ID: 33545070)
21. Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a.
Miranda TB; Webb KJ; Edberg DD; Reeves R; Clarke S
Biochem Biophys Res Commun; 2005 Oct; 336(3):831-5. PubMed ID: 16157300
[TBL] [Abstract][Full Text] [Related]
22. Effect of phosphorylation on the structure and fold of transactivation domain of p53.
Kar S; Sakaguchi K; Shimohigashi Y; Samaddar S; Banerjee R; Basu G; Swaminathan V; Kundu TK; Roy S
J Biol Chem; 2002 May; 277(18):15579-85. PubMed ID: 11854266
[TBL] [Abstract][Full Text] [Related]
23. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
[TBL] [Abstract][Full Text] [Related]
24. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
25. The nuclear architectural protein HMGA1a triggers receptor-mediated endocytosis.
Wu W; Wan W; Li AD
J Cell Biochem; 2009 Nov; 108(4):791-801. PubMed ID: 19739099
[TBL] [Abstract][Full Text] [Related]
26. Interactions between p53, hMSH2-hMSH6 and HMG I(Y) on Holliday junctions and bulged bases.
Subramanian D; Griffith JD
Nucleic Acids Res; 2002 Jun; 30(11):2427-34. PubMed ID: 12034830
[TBL] [Abstract][Full Text] [Related]
27. Modulating protein-DNA interactions by post-translational modifications at disordered regions.
Vuzman D; Hoffman Y; Levy Y
Pac Symp Biocomput; 2012; ():188-99. PubMed ID: 22174274
[TBL] [Abstract][Full Text] [Related]
28. High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria.
Esposito F; Tornincasa M; Federico A; Chiappetta G; Pierantoni GM; Fusco A
Cell Death Dis; 2012 Aug; 3(8):e383. PubMed ID: 22932725
[TBL] [Abstract][Full Text] [Related]
29. Structural modulation of p53TAD1-TAZ2 complex upon mutations and post-translational modification.
Ghosh A; Ganguly D
J Biomol Struct Dyn; 2023 Jan; 41(1):176-185. PubMed ID: 34787057
[TBL] [Abstract][Full Text] [Related]
30. A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.
Sun X; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443163
[TBL] [Abstract][Full Text] [Related]
31. Enhanced Binding Affinity via Destabilization of the Unbound State: A Millisecond Hydrogen-Deuterium Exchange Study of the Interaction between p53 and a Pleckstrin Homology Domain.
Zhu S; Khatun R; Lento C; Sheng Y; Wilson DJ
Biochemistry; 2017 Aug; 56(32):4127-4133. PubMed ID: 28696098
[TBL] [Abstract][Full Text] [Related]
32. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis for the inhibition of HMGA1 proteins by distamycin A.
Smith AE; Buchmueller KL
Biochemistry; 2011 Sep; 50(38):8107-16. PubMed ID: 21854010
[TBL] [Abstract][Full Text] [Related]
34. Site-specific phosphorylation of human p53 protein determined by mass spectrometry.
Merrick BA; Zhou W; Martin KJ; Jeyarajah S; Parker CE; Selkirk JK; Tomer KB; Borchers CH
Biochemistry; 2001 Apr; 40(13):4053-66. PubMed ID: 11300786
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the disordered conformational ensembles of the p53 transactivation domain by cancer-associated mutations.
Ganguly D; Chen J
PLoS Comput Biol; 2015 Apr; 11(4):e1004247. PubMed ID: 25897952
[TBL] [Abstract][Full Text] [Related]
36. Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry.
Abraham J; Kelly J; Thibault P; Benchimol S
J Mol Biol; 2000 Jan; 295(4):853-64. PubMed ID: 10656795
[TBL] [Abstract][Full Text] [Related]
37. Post-translational modifications and activation of p53 by genotoxic stresses.
Appella E; Anderson CW
Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
[TBL] [Abstract][Full Text] [Related]
38. A link between apoptosis and degree of phosphorylation of high mobility group A1a protein in leukemic cells.
Diana F; Sgarra R; Manfioletti G; Rustighi A; Poletto D; Sciortino MT; Mastino A; Giancotti V
J Biol Chem; 2001 Apr; 276(14):11354-61. PubMed ID: 11145960
[TBL] [Abstract][Full Text] [Related]
39. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
Brocher J; Vogel B; Hock R
BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
[TBL] [Abstract][Full Text] [Related]
40. Modulation of p53 N-terminal transactivation domain 2 conformation ensemble and kinetics by phosphorylation.
Zhao L; Ouyang Y; Li Q; Zhang Z
J Biomol Struct Dyn; 2020 Jun; 38(9):2613-2623. PubMed ID: 31248328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
